Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives

Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives

Potent, cell-permeable, and subtype-selective sialyltransferase inhibitors represent an attractive family of substances that can potentially be used for the clinical treatment of cancer metastasis. These substances operate by specifically inhibiting sialyltransferase-mediated hypersialylation of cel...

Full description

Bibliographic Details
Main Authors: Ser John Lynon P. Perez, Chih-Wei Fu, Wen-Shan Li
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Molecules
Subjects:
sialyltransferase
hypersialylation
cancer metastasis
sialyltransferase inhibitors
drug design and development
Online Access:https://www.mdpi.com/1420-3049/26/18/5673

Internet

https://www.mdpi.com/1420-3049/26/18/5673

Similar Items